Showing results (221-230 of 283) with videos related to

Sort By:
Pageof 29
JAMA Network Open|October 26, 2019
Machine Learning Approaches to Predict 6-Month Mortality Among Patients With CancerRavi B Parikh, Christopher Manz, Corey Chivers, et al.
NEJM AI|July 22, 2024
Spending Analysis of Machine Learning-Based Communication Nudges in OncologyTej A Patel, Jonathan Heintz, Jinbo Chen, et al.
Genes, Chromosomes & Cancer|October 7, 2014
Aberrant TP53 detected by combining immunohistochemistry and DNA-FISH improves Barrett's esophagus progression prediction: a prospective follow-up studyAkueni L Davelaar, Silvia Calpe, Liana Lau, et al.
Blood|August 9, 2001
T-cell--depleted allogeneic bone marrow transplantation followed by donor lymphocyte infusion in patients with multiple myeloma: induction of graft-versus-myeloma effectE Alyea, E Weller, R Schlossman, et al.
JAMA Network Open|September 28, 2020
Comparison by Race of Conservative Management for Low-Risk and Intermediate-Risk Prostate Cancers in Veterans From 2004 to 2018Ravi B Parikh, Kyle W Robinson, Sumedha Chhatre, et al.
International Journal of Radiation Oncology, Biology, Physics|May 29, 2014
Definitive primary therapy in patients presenting with oligometastatic non-small cell lung cancerRavi B Parikh, Angel M Cronin, David E Kozono, et al.
BMJ Open|March 24, 2023
Behavioural economic interventions to embed palliative care in community oncology (BE-EPIC): study protocol for the BE-EPIC randomised controlled trialRavi B Parikh, Ramy Sedhom, William J Ferrell, et al.
European Urology|August 1, 2019
Effectiveness of First-line Immune Checkpoint Blockade Versus Carboplatin-based Chemotherapy for Metastatic Urothelial CancerEmily Feld, Joanna Harton, Neal J Meropol, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 30, 2022
Clinician perspectives on machine learning prognostic algorithms in the routine care of patients with cancer: a qualitative studyRavi B Parikh, Christopher R Manz, Maria N Nelson, et al.
Future Oncology (London, England)|December 17, 2019
First-line immune checkpoint inhibitor use in cisplatin-eligible patients with advanced urothelial carcinoma: a secular trend analysisRavi B Parikh, Emily K Feld, Matthew D Galsky, et al.
Pageof 29